AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 53 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154 | +569.6% | 100,854 | +622.9% | 0.01% | +550.0% |
| Q2 2023 | $23 | -99.9% | 13,952 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | -82.4% | 13,704 | -60.6% | 0.00% | -83.3% |
| Q1 2022 | $91,000 | -76.1% | 34,769 | -64.4% | 0.01% | -75.0% |
| Q4 2021 | $380,000 | -70.7% | 97,802 | -67.1% | 0.05% | -63.6% |
| Q3 2021 | $1,296,000 | +234.0% | 297,229 | +203.9% | 0.13% | +200.0% |
| Q2 2021 | $388,000 | -64.1% | 97,801 | -52.9% | 0.04% | -75.4% |
| Q1 2021 | $1,080,000 | +1267.1% | 207,609 | +1721.1% | 0.18% | +2137.5% |
| Q1 2019 | $79,000 | – | 11,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |